Avalo Therapeutics Statistics

Total Valuation

AVTX has a market cap or net worth of $95.11 million. The enterprise value is $14.89 million.

Market Cap	95.11M
Enterprise Value	14.89M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

AVTX has 10.46 million shares outstanding. The number of shares has increased by 2,315.84% in one year.

Current Share Class	10.46M
Shares Outstanding	10.46M
Shares Change (YoY)	+2,315.84%
Shares Change (QoQ)	-53.89%
Owned by Insiders (%)	5.26%
Owned by Institutions (%)	13.16%
Float	2.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.95
Forward PS	n/a
PB Ratio	4.18
P/TBV Ratio	9.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	18.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.07.

Current Ratio	1.42
Quick Ratio	1.37
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.52% and return on invested capital (ROIC) is -95.33%.

Return on Equity (ROE)	-42.52%
Return on Assets (ROA)	-30.64%
Return on Capital (ROIC)	-95.33%
Revenue Per Employee	$43,158
Profits Per Employee	-$428,158
Employee Count	19
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-9,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.37% in the last 52 weeks. The beta is 0.89, so AVTX's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-32.37%
50-Day Moving Average	11.11
200-Day Moving Average	11.06
Relative Strength Index (RSI)	39.42
Average Volume (20 Days)	144,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AVTX had revenue of $820,000 and -$8.14 million in losses. Loss per share was -$75.46.

Revenue	820,000
Gross Profit	-9.34M
Operating Income	-31.31M
Pretax Income	-142.87M
Net Income	-8.14M
EBITDA	-31.17M
EBIT	-31.31M
Loss Per Share	-$75.46

Full Income Statement

Balance Sheet

The company has $81.86 million in cash and $1.63 million in debt, giving a net cash position of $80.23 million or $7.67 per share.

Cash & Cash Equivalents	81.86M
Total Debt	1.63M
Net Cash	80.23M
Net Cash Per Share	$7.67
Equity (Book Value)	22.73M
Book Value Per Share	2.18
Working Capital	25.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-36.78M
Capital Expenditures	n/a
Free Cash Flow	-36.78M
FCF Per Share	-$3.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,818.41%
Pretax Margin	-971.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,315.84%
Shareholder Yield	-2,315.84%
Earnings Yield	-8.55%
FCF Yield	-38.67%

Analyst Forecast

The average price target for AVTX is $33.00, which is 263.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.00
Price Target Difference	263.04%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.

Last Split Date	Dec 29, 2023
Split Type	Reverse
Split Ratio	0.0041667:1

Scores

AVTX has an Altman Z-Score of -5.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.32
Piotroski F-Score	n/a